A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)

NCT01163747 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Rheumatoid Arthritis

Interventions

BIOLOGICAL: tocilizumab
DRUG: methotrexate
BIOLOGICAL: 23-Valent Pneumococcal Polysaccharide Vaccine
BIOLOGICAL: Tetanus Toxoid Adsorbed Vaccine

Sponsor

Genentech, Inc.